Speaker: Dr. Jan Voskuil has over thirty years accrued knowledge and experience in both academic and commercial environments on antibody and assay development. He set up the consultation and vending company Aeonian Biotech to deliver a new proprietary concept of selecting research antibodies from an increasingly complex market. Aeonian Biotech offers help to the relevant industries and to their customers to meet the quality requirements in the aftermath of recent international meetings on this subject. Dr. Voskuil has been the driving force behind the growth and quality of the Everest Biotech antibody catalogue, and an active expert member in discussions in relevant LinkedIn discussion groups. As Chief Scientific Officer, he was the direct contact for custom antibody services and for technical support and wrote all content in the technical support web pages of Everest Biotech. Dr. Voskuil is also active in the world of biomarkers. Through thorough reputation building, the company has transformed to a profit-generating enterprise with increasing frequency and amounts of dividends.
Speaker: Dr. Anita Bandrowski is a neurophysiologist by training, but for the past decade she has been working in the area of neuro-informatics to increase access to and utilization of neuroscience data. Just as science was able to harness the power of the printing press to foster scientific communication and collaboration, she believes we must now establish the means for communicating and utilizing the digital technologies for scientific communication and discovery. For this reason, she has been working in the area of knowledge representation in the neurosciences within the Neuroscience Information Framework (NIF). She is the scientific lead of the NIF project, which under her direction has grown into the largest source of neuroscience data and tools on the web. Through NIF and her neuroscience background, she has a unique global perspective on issues in data sharing and utilization in the neurosciences and has gained considerable insight and expertise in working with diverse biomedical data. She and her colleagues have recently extended the NIF framework to develop data portals for NIDDK (dkNET) and the RRID community portal. Dr. Bandrowski serves as the lead for the Resource Identification Initiative, a FORCE11, the Future of Research Communications and e-Scholarship, group dedicated to transforming scholarly communication. RRIDs are unique identifiers for Key Biological Resources, aggregated by our group from community databases and requested from authors in participating journals, including Cell and eLife. Her background in working in Neuroscience data, bioinformatics and ontology development makes Dr. Bandrowski well suited to lead SciCrunch, a technology startup focused on making sense of big biological data.
Dr. Simon Goodman moderates this webinar series.
References from Dr. Voskuil:
- Voskuil JL. The challenges with the validation of research antibodies. F1000Res. 2017;6:161.
- Voskuil J. How difficult is the validation of clinical biomarkers? F1000Res. 2015;4:101.
- Voskuil J. Biomarkers and their dependence on well-reported antibodies. Per Med. 2015;12(6):545-8.
- Voskuil JLA. Commercial antibodies and their validation. F1000Res. 2014;3:232.
References from Dr. Bandrowski:
- Babic Z, Capes-Davis A, Martone ME, Bairoch A, Ozyurt IB, Gillespie TH, et al. Incidences of problematic cell lines are lower in papers that use RRIDs to identify cell lines. Elife. 2019;8.
- Bandrowski AE, Martone ME. RRIDs: A Simple Step toward Improving Reproducibility through Rigor and Transparency of Experimental Methods. Neuron. 2016;90(3):434-6.
- Bandrowski A, Brush M, Grethe JS, Haendel MA, Kennedy DN, Hill S, et al. The Resource Identification Initiative: A cultural shift in publishing. F1000Res. 2015;4:134.
